Sort
326,823 grants matching “clinical trial”
Cancer Center Administration
$2,340,000Sharon Gail Levy · Georgetown University · P30 · FY2023 · CA
Hepatobiology and Toxicology COBRE
$2,340,000Craig J McClain · University Of Louisville · P20 · FY2021 · GM
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
$2,340,000Louis M Weiner · Georgetown University · P30 · FY2023 · CA
Next generation brain-machine interfaces controlled synergistically with artificial intelligence
$2,340,000Jonathan Chau-Yan Kao · University Of California Los Angeles · DP2 · FY2020 · NS
Prostate Section
$2,339,854Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Translational development of new agents alone and in combination to combat Gram-negative pathogens important in Ventilator- Associated Bacterial Pneumonia: Leveraging the Gram-negative toolbox that is
$2,339,559Arnold Louie · University Of Florida · P01 · FY2025 · AI
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
$2,339,503Laura J Esserman · University Of California, San Francisco · P01 · FY2017 · CA
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
$2,339,500Ying Yuan · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · DK
US POINTER Neuroimaging Ancillary Study
$2,339,411Susan M Landau · University Of California Berkeley · R01 · FY2025 · AG
Longitudinal Imaging Biomarkers of Prodromal DLB
$2,339,366Kejal Kantarci · Mayo Clinic Rochester · U01 · FY2024 · NS
New Approaches to Gene Therapy for Alpha-1 Antitrypsin Deficiency
$2,339,301Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2020 · HL
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts
$2,339,148Flavio Vincenti · University Of California, San Francisco · U01 · FY2018 · AI
Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease
$2,338,814William C Raschke · Virogenics, Inc. · R01 · FY2022 · AG
Identification and regulation of signal transduction pathways that promote survi
$2,338,621Phillip A. Dennis · Clinical Sciences · Z01 · FY2007 · CA
Development of Akt Inhibitors
$2,338,621Phillip A. Dennis · Basic Sciences · Z01 · FY2007 · CA
Regulatory Support for Cancer Prevention Agent Development
$2,338,262Caroline C Sigman · Ccs Associates, Inc. · N02 · FY2017 · CA
Translational Immunology research: a support for clinical immunological research
$2,338,004Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2011 · AR
Screening, Tracking and Treatment for Anxiety and Depression in Community Colleges
$2,337,984Michelle G Craske · University Of California Los Angeles · P50 · FY2024 · MH
Genetic and Environmental Determinants of Triglycerides
$2,337,955University Of Minnesota Twin Cities · U01 · FY2002 · HL
Molecular Therapeutics for Anaplastic Gliomas
$2,337,738University Of Alabama At Birmingham · P50 · FY2004 · CA
COORDINATING CENTER FOR AMD PREVENTION TRIAL
$2,337,716University Of Pennsylvania · U10 · FY2002 · EY
Center for Cancer Immunology and Immunotherapy (CCII)
$2,337,631Jun Yan · University Of Louisville · P20 · FY2020 · GM
Brain Tumor SPORE Grant
$2,337,554Mitchel S. Berger · University Of California, San Francisco · P50 · FY2024 · CA
The Kansas Institute for Precision Medicine
$2,337,371Andrew K Godwin · University Of Kansas Medical Center · P20 · FY2024 · GM
Analysis of cancer-related immune suppressor mechanisms in mice
$2,337,175Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA